Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read More
Building Time-Series Machine Learning Models with sktime in Python
The landscape of machine learning has seen significant evolution, yet specialized tools for time series data have long presented a…
Read More
7 Steps to Mastering Time Series Analysis with Python
The Ubiquity and Strategic Importance of Time Series Data Time series data, characterized by observations recorded sequentially over time, permeates…
Read More
Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…
Read More
Time-Series Feature Engineering with Python Itertools
The Distinctive Nature of Time Series Data and Feature Engineering Time series data, characterized by sequential observations indexed by time,…
Read More
Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development
AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…
Read More
Unlocking the Power of Time Series Analysis: Five Essential Python Scripts for Data Professionals
The relentless proliferation of data across virtually every sector of the global economy has underscored the critical importance of sophisticated…
Read More
Ray Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration Pipeline
Ray Therapeutics, a biopharmaceutical company at the forefront of developing novel gene therapies for vision restoration, has successfully closed a…
Read More
Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases
Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…
Read More
Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline
Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…
Read MoreYOU MAY HAVE MISSED
